OverviewSuggest Edit

Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. The Company's lead product, ilixadencel, has been developed to be able to take advantage of each patient's own tumor antigen. Immunicum is also engaged in research and development for production of pharmaceuticals.

TypePublic
Founded2002
HQStockholm, SE
Websiteimmunicum.se

Latest Updates

Employees (est.) (Feb 2019)11(-15%)
Share Price (May 2020)KR9.7 (-2%)

Key People/Management at Immunicum

Michael Oredsson

Michael Oredsson

Chairman
Michaela Gertz

Michaela Gertz

Chief Financial Officer
Alex Karlsson-Parra

Alex Karlsson-Parra

Interim Chief Executive Officer
Charlotte Edenius

Charlotte Edenius

Board Member
Magnus Persson

Magnus Persson

Board Member
Steven Glazer

Steven Glazer

Board Member
Show more

Immunicum Office Locations

Immunicum has an office in Stockholm
Stockholm, SE (HQ)
Östermalmstorg 5
Show all (1)

Immunicum Financials and Metrics

Immunicum Revenue

Market capitalization (27-Apr-2020)

728.8m

Closing stock price (27-Apr-2020)

7.9
Immunicum's current market capitalization is kr728.8 m.
Show all financial metrics

Immunicum Online and Social Media Presence

Embed Graph

Immunicum Blogs

Corporate Presentation – February 2020

Click here to view our most recent corporate presentation: February 2020  

ASCO-SITC MERECA Podium Presentation

A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous... Read more

ASCO-SITC GIST Poster now available under publications

Immunicum/technology/publications

BioStock Interview with COO Sijme Zeilemaker

Immunicum COO, Sijme Zeilemaker, was interviewed by BioStock. Sijme answered questions about the current landscape and upcoming updates... Read more

RedEye Interview with Michael Oredsson, Chairman of the Board

  Chairman of the Board, Michael Oredsson, was interviewed by RedEye this morning in regards to the change... Read more

Presentation at BioStock Life Science Summit

Our Senior Director Business Development, Sijme Zeilemaker, had the opportunity to present at the BioStock Life Science Summit.... Read more
Show more

Immunicum Frequently Asked Questions

  • When was Immunicum founded?

    Immunicum was founded in 2002.

  • Who are Immunicum key executives?

    Immunicum's key executives are Michael Oredsson, Michaela Gertz and Alex Karlsson-Parra.

  • How many employees does Immunicum have?

    Immunicum has 11 employees.

  • Who are Immunicum competitors?

    Competitors of Immunicum include Retrophin, Palatin Technologies and GBT (Global Blood Therapeutics).

  • Where is Immunicum headquarters?

    Immunicum headquarters is located at Östermalmstorg 5, Stockholm.

  • Where are Immunicum offices?

    Immunicum has an office in Stockholm.

  • How many offices does Immunicum have?

    Immunicum has 1 office.